Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate

This publication has 12 references indexed in Scilit:

• A new 1‐week therapy for Helicobacter pylori eradication: rani‐ tidine bismuth citrate plus two antibiotics
  Alimentary Pharmacology & Therapeutics, 1997
• Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report
  European Journal of Gastroenterology & Hepatology, 1997
• Helicobacter pylori eradication using one‐week low‐dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin
  Alimentary Pharmacology & Therapeutics, 1996
• Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
  Helicobacter, 1996
• Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group [see comments]
  Alimentary Pharmacology & Therapeutics, 1996
• Comparison of One or Two Weeks of Lansoprazole, Amoxicillin, and Clarithromycin in the Treatment of Helicobacter pylori
  Helicobacter, 1996
• One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection
  Alimentary Pharmacology & Therapeutics, 1996
• The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer Disease
  New England Journal of Medicine, 1995
• Short-term low-dose triple therapy for the eradication of Helicobacter pylori
  European Journal of Gastroenterology & Hepatology, 1994
• Review article: Helicobacter pylori eradication–understandable caution but no excuse for inertia
  Alimentary Pharmacology & Therapeutics, 1994